Neha Bhagwat

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index5.5kcitations167works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related gene regulation(45), Chromatin Remodeling and Cancer(31), Extracellular vesicles in disease(27), Protein Degradation and Inhibitors(25), Mechanisms of cancer metastasis(23)

Publications167 total

Figure S10 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Figure S8 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Table S3 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Figure S6 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Table S5 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Table S6 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Table S7 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Figure S5 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Figure S11 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Figure S4 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Table S1 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Data from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Figure S7 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Figure S3 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Table S4 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Table S2 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Figure S9 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Figure S2 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Figure S1 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in <i>SMARCA4</i>-Mutated Cancers
2026Open Access
Discovery of first-in-class calr-targeted precision ADCs delivering a CDK9degrader payload for the treatment of calr-mutated MPNs
Blood·2025· 1 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Ross L. Levine(20), Peggy Scherle(20), Kris Vaddi(11), Erica L. Carpenter(10), Priya Koppikar(9), Alexander Grego(9), Omar Abdel‐Wahab(8), Sachie Marubayashi(8), Stephanie S. Yee(7), Joseph Rager(7), Bruce Ruggeri(7), Gabriela Chiosis(6), Ben Z. Stanger(6), Matthew D. Keller(5), Monisha Sivakumar(5), Venkat Thodima(5), Srđan Verstovšek(4), Maria Kleppe(4), Raajit K. Rampal(4), Jina Ko(4)